Despite the surge, Cheng believes believe BCRX shares remain “underappreciated by investors” with a valuation “disconnected from its fundamentals.”
Accordingly, the analyst rates BCRX an Overweight (i.e. Buy) and his $21 price target suggests shares will climb ~28% over the next 12 months. (To watch Cheng’s track record, click here)
Two skeptics aside, all other 8 recent analyst reviews are positive, providing BCRX with a Strong Buy consensus rating. The $21.10 average target is just slightly above Cheng’s objective. (See BCRX stock analysis on TipRanks)